These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 858437)

  • 1. [The effect of bloodletting on the excretion of porphyrius and clelta aminolevulinic acid as well as the clinical picture of porphyria cutanea tarda].
    Broese I; Mattheus A
    Dermatol Monatsschr; 1977 Feb; 163(2):111-8. PubMed ID: 858437
    [No Abstract]   [Full Text] [Related]  

  • 2. [Porphyrins and their precursors in the urine of patients with suspected porphyria; a 16-year experience].
    Zawirska B; Kwiatkowska W; Nowojska A
    Pol Tyg Lek; 1985 Jan; 40(4):97-100. PubMed ID: 3983004
    [No Abstract]   [Full Text] [Related]  

  • 3. [3 cases of porphyria cutanea tarda--change of urinary porphyrin excretion patterns after phlebotomy].
    Murayama F; Ohgami T; Honda T; Rikimaru M; Hirowatari T; Nonaka S; Yoshida H
    Nihon Hifuka Gakkai Zasshi; 1983 Aug; 93(9):909-15. PubMed ID: 6663799
    [No Abstract]   [Full Text] [Related]  

  • 4. [Results of treatment of porphyria cutanea tarda with bloodletting and chloroquine].
    Seubert S; Seubert A; Stella AM; Guzman H; Batlle A
    Z Hautkr; 1990 Mar; 65(3):223-5. PubMed ID: 2339575
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Phlebotomy treatment in cases of porphyria cutanea tarda].
    Lundvall O
    Lakartidningen; 1968 Jun; 65(23):2667-77. PubMed ID: 5721515
    [No Abstract]   [Full Text] [Related]  

  • 6. Porphyria cutanea tarda. A study of the effect of phlebotomy.
    Epstein JH; Redeker AG
    N Engl J Med; 1968 Dec; 279(24):1301-4. PubMed ID: 5697519
    [No Abstract]   [Full Text] [Related]  

  • 7. Treatment of porphyria cutanea tarda with chloroquine and phlebotomy.
    Swanbeck G; Wennersten G
    Br J Dermatol; 1977 Jul; 97(1):77-81. PubMed ID: 889703
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Letter: Porphyria cutanea tarda: normalization of porphyrin-excretion following treatment with p-amino-benzoic acid (Potaba) (author's transl)].
    Goerz G; Krieg T; Bolsen K
    Arch Dermatol Res (1975); 1976 Jun; 255(3):331-5. PubMed ID: 942260
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute intermittent porphyria.
    Day RS; Eales L
    S Afr Med J; 1982 Feb; 61(8):260-1. PubMed ID: 7058452
    [No Abstract]   [Full Text] [Related]  

  • 10. [Porphyria cutanea tarda].
    Velde KT; Noordhoek KH
    Ned Tijdschr Geneeskd; 1976 May; 120(22):952-7. PubMed ID: 1272435
    [No Abstract]   [Full Text] [Related]  

  • 11. [Experiences with iron elimination therapy in porphyria cutanea tarda].
    Haneke E; Schwartze G
    Z Gesamte Inn Med; 1971 Nov; 26(22):710-6. PubMed ID: 5141034
    [No Abstract]   [Full Text] [Related]  

  • 12. Five cases of porphyria cutanea tarda with mild cutaneous changes: evaluation of the efficacy of phlebotomy by the pattern analysis of urinary porphyrins.
    Nonaka S; Ohgami T; Murayama F; Yamashita K; Yoshida H
    J Dermatol; 1986 Jun; 13(3):196-202. PubMed ID: 3537046
    [No Abstract]   [Full Text] [Related]  

  • 13. Porphyria cutanea tarda-a genetic disease? A biochemical and fluorescence microscopical study in four families.
    Dehlin O; Enerbäck L; Lundvall O
    Acta Med Scand; 1973 Oct; 194(4):265-70. PubMed ID: 4749164
    [No Abstract]   [Full Text] [Related]  

  • 14. [Porphyria cutanea tarda: possible treatment and its results (author's transl)].
    Goerz G; Krieg T
    Dtsch Med Wochenschr; 1978 Aug; 103(34):1329-33. PubMed ID: 308001
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Chloroquine therapy in porphyria cutanea tarda].
    Snitker G
    Ugeskr Laeger; 1971 Aug; 133(33):1605-10. PubMed ID: 5099470
    [No Abstract]   [Full Text] [Related]  

  • 16. Porphyria cutanea tarda treated by repeated venesection: clinical and biochemical response.
    Baker H; Turnbull A
    Proc R Soc Med; 1969 Jun; 62(6):590-2. PubMed ID: 5802737
    [No Abstract]   [Full Text] [Related]  

  • 17. [Excretion of porphyrin and porphyrin precursor during ethylene oxide inhalation].
    Fujishiro K; Inoue N; Mori K; Ikeda M; Hori H
    J UOEH; 1989 Mar; 11(1):23-8. PubMed ID: 2717830
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Biochemistry of the regression and latent phase of porphyria cutanea tarda].
    Peschlow I; Schlenzka K
    Dermatol Monatsschr; 1983 Feb; 169(2):85-91. PubMed ID: 6840368
    [No Abstract]   [Full Text] [Related]  

  • 19. [Pathophysiology and diagnosis of acute intermittent porphyria].
    Wichmann T; Freye HA
    Z Gesamte Inn Med; 1977 Jun; 32(12):289-92. PubMed ID: 910533
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The treatment of porphyria cutanea tarda by venesection.
    Ramsay CA; Magnus IA; Turnbull A; Baker H
    Q J Med; 1974 Jan; 43(169):1-24. PubMed ID: 4822971
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.